PharmaShots | Incisive News in 3 Shots

Subscribe Now

BRAF V600E Mutation

The US FDA Approves New Indication for Lilly's Erbitux (cetuximab) + Braftovi (encorafenib) to Treat Metastatic Colorectal Cancer with a BRAF V600E Mutation

The US FDA Approves New Indication for Lilly's Erbitux (cetuximab) + Braftovi (encorafenib) to Treat Metastatic Colorectal Cancer...

September 29, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us